181 related articles for article (PubMed ID: 7578383)
1. Osteosarcoma and other tumors of bone.
Mertens WC; Bramwell V
Curr Opin Oncol; 1995 Jul; 7(4):349-54. PubMed ID: 7578383
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma and other tumors of bone.
Mertens WC; Bramwell V
Curr Opin Oncol; 1994 Jul; 6(4):384-90. PubMed ID: 7803539
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
[TBL] [Abstract][Full Text] [Related]
4. Current and future therapeutic approaches for osteosarcoma.
Harrison DJ; Geller DS; Gill JD; Lewis VO; Gorlick R
Expert Rev Anticancer Ther; 2018 Jan; 18(1):39-50. PubMed ID: 29210294
[TBL] [Abstract][Full Text] [Related]
5. Osteosarcoma and other tumors of bone.
Mertens WC; Bramwell VC
Curr Opin Oncol; 1997 Jul; 9(4):360-5. PubMed ID: 9251886
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of p53 alterations in human osteosarcoma: a meta analysis.
Yao D; Cai GH; Chen J; Ling R; Wu SX; Li YP
Int J Clin Exp Pathol; 2014; 7(10):6725-33. PubMed ID: 25400752
[TBL] [Abstract][Full Text] [Related]
7. Progress in the treatment of osteosarcoma.
Chang P
Med Clin North Am; 1977 Sep; 61(5):1027-38. PubMed ID: 408567
[No Abstract] [Full Text] [Related]
8. Sensitization of osteosarcoma cell line SaOS-2 to chemotherapy by downregulating survivin.
Zou J; Gan M; Mao N; Zhu X; Shi Q; Yang H
Arch Med Res; 2010 Apr; 41(3):162-9. PubMed ID: 20682173
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of Primary Osteosarcoma in Elderly Patients: A Comparison between Young and Elderly Patients.
Tsuchie H; Emori M; Nagasawa H; Miyakoshi N; Murahashi Y; Shimizu J; Mizushima E; Yamashita T; Shimada Y
Med Princ Pract; 2019; 28(5):425-431. PubMed ID: 30991396
[TBL] [Abstract][Full Text] [Related]
10. High-dose chemotherapy with stem cell rescue in the primary treatment of metastatic and pelvic osteosarcoma: final results of the ISG/SSG II study.
Boye K; Del Prever AB; Eriksson M; Saeter G; Tienghi A; Lindholm P; Fagioli F; Skjeldal S; Ferrari S; Hall KS
Pediatr Blood Cancer; 2014 May; 61(5):840-5. PubMed ID: 24254749
[TBL] [Abstract][Full Text] [Related]
11. Review of management issues in relapsed osteosarcoma.
Vijayamurugan N; Bakhshi S
Expert Rev Anticancer Ther; 2014 Feb; 14(2):151-61. PubMed ID: 24308680
[TBL] [Abstract][Full Text] [Related]
12. Historical, current and future aspects of osteosarcoma treatment.
Ham SJ; Schraffordt Koops H; van der Graaf WT; van Horn JR; Postma L; Hoekstra HJ
Eur J Surg Oncol; 1998 Dec; 24(6):584-600. PubMed ID: 9870738
[No Abstract] [Full Text] [Related]
13. Primary chemotherapy and delayed surgery for nonmetastatic osteosarcoma of the extremities. Results in 164 patients preoperatively treated with high doses of methotrexate followed by cisplatin and doxorubicin.
Bacci G; Picci P; Ferrari S; Ruggieri P; Casadei R; Tienghi A; Brach del Prever A; Gherlinzoni F; Mercuri M; Monti C
Cancer; 1993 Dec; 72(11):3227-38. PubMed ID: 8242546
[TBL] [Abstract][Full Text] [Related]
14. [Neoadjuvant therapy for localized osteosarcoma of extremities. Results from the Cooperative osteosarcoma study group COSS of 925 patients].
Bielack S; Kempf-Bielack B; Schwenzer D; Birkfellner T; Delling G; Ewerbeck V; Exner GU; Fuchs N; Göbel U; Graf N; Heise U; Helmke K; von Hochstetter AR; Jürgens H; Maas R; Münchow N; Salzer-Kuntschik M; Treuner J; Veltmann U; Werner M; Winkelmann W; Zoubek A; Kotz R
Klin Padiatr; 1999; 211(4):260-70. PubMed ID: 10472560
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
16. Common musculoskeletal tumors of childhood and adolescence.
Arndt CA; Crist WM
N Engl J Med; 1999 Jul; 341(5):342-52. PubMed ID: 10423470
[No Abstract] [Full Text] [Related]
17. Treatment of osteosarcoma: experience of the Cooperative Osteosarcoma Study Group (COSS).
Winkler K; Bielack SS; Delling G; Jürgens H; Kotz R; Salzer-Kuntschik M
Cancer Treat Res; 1993; 62():269-77. PubMed ID: 7682088
[TBL] [Abstract][Full Text] [Related]
18. Common variations in ERCC2 are associated with response to cisplatin chemotherapy and clinical outcome in osteosarcoma patients.
Caronia D; Patiño-García A; Milne RL; Zalacain-Díez M; Pita G; Alonso MR; Moreno LT; Sierrasesumaga-Ariznabarreta L; Benítez J; González-Neira A
Pharmacogenomics J; 2009 Oct; 9(5):347-53. PubMed ID: 19434073
[TBL] [Abstract][Full Text] [Related]
19. Osteosarcoma and other tumors of bone.
Mertens WC; Bramwell VH
Curr Opin Oncol; 1996 Jul; 8(4):299-304. PubMed ID: 8869804
[TBL] [Abstract][Full Text] [Related]
20. Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes.
Xu M; Xu S; Yu X
World J Surg Oncol; 2014 Nov; 12():341. PubMed ID: 25391880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
